Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity.

Ferreira AMDC, Schneider-Stock R, Aiello F (2022)

Publication Type: Journal article, Editorial

Publication year: 2022

Journal

Frontiers in Molecular Biosciences Frontiers Media

Book Volume: 9

DOI: 10.3389/fmolb.2022.859821

Authors with CRIS profile

Regine Schneider-Stock Professur für Experimentelle Tumorpathologie

Involved external institutions

University of São Paulo / Universidade de São Paulo (USP) BR Brazil (BR) Università della Calabria (UNICAL) IT Italy (IT)

How to cite

APA:

Ferreira, A.M.D.C., Schneider-Stock, R., & Aiello, F. (2022). Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity. Frontiers in Molecular Biosciences, 9. https://doi.org/10.3389/fmolb.2022.859821

MLA:

Ferreira, Ana Maria Da Costa, Regine Schneider-Stock, and Francesca Aiello. "Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity." Frontiers in Molecular Biosciences 9 (2022).

BibTeX: Download